EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021 · DOI: 10.3892/etm.2021.10143 · Published: February 2, 2021
This study investigates the role of STAT3, a protein involved in cell signaling, in neural stem cells (NSCs) after spinal cord injury (SCI). The researchers found that inhibiting STAT3 in NSCs promotes their differentiation into neurons rather than glial cells. The researchers transplanted NSCs with inhibited STAT3 into rats with SCI. The results showed improved functional recovery and tissue repair in the rats that received the modified NSCs. The findings suggest that using NSCs with STAT3 knocked down could enhance regenerative cell therapy for SCI, offering a potential new approach to treatment.
STAT3 inhibition in NSCs holds promise for enhancing regenerative cell therapy for spinal cord injury.
The study suggests a targeted approach to SCI treatment by manipulating STAT3 expression in transplanted NSCs.
The findings contribute to a better understanding of the role of STAT3 in NSC differentiation and its potential for therapeutic intervention.